MENU
 

PRE TAX NTA |$3.76

Value as at close of business on 17 January 2024

Big thinkers in hunt for brain cancer cure

Picture: Professor Misty Jenkins and Professor Daniel MacArthur

Melbourne scientist Misty Jenkins has had a long-time interest in immunology.

But it was a neuroscientist friend of hers who urged her to focus her skills on seeking a cure for brain ­cancer. 

“I’m sick of telling my patients they are going to die,” her friend told her. “Someone needs to do something about it.”

“Brain cancer is rare, but for people who do get it the prognosis is not good,” Assistant Professor Jenkins tells The Australian.

 Brain stem tumours in children are 100 per cent fatal.

“Brain cancer kills more children than any other disease,” she says.

“If a child is diagnosed with brain cancer, the parents are basically told to take them home and ‘make ­memories’.”

Adults may have more time – as much as 18 months – but few make it through to the five-year cancer-free stage.

Seven years ago, with financial support from several philanthropists, Jenkins founded a laboratory at the Walter and Eliza Hall Institute for Medical Research in Melbourne to focus specifically on finding a cure for brain cancer.

Thanks to grants of $600,000 over two years that her colleague Professor Matt Call received from the annual Sohn Hearts and Minds conference, her laboratory has been able to develop its research into ways to combat brain cancer to the stage where they are ready for clinical trials in humans.

Jenkins, an associate professor at the Institute, will be a speaker at this year’s Sohn conference in Sydney, outlining the unique approach to combating brain cancer she and her team are working on. 

The annual conference, where people pay to hear the stock tips of local and global fund managers, has raised $60m for medical research since it began in Australia in 2016.

The research at the Institute is aimed at using the body’s own immune system to attack the cancer in the brain. It uses chimeric antigen receptor T (CAR T) cells to identify and attack brain tumours.

Seven years ago, Misty Jenkins founded a laboratory at the Walter and Eliza Hall Institute for Medical Research in Melbourne to focus specifically on finding a cure for brain cancer.

The focus is on designing receptors to be expressed by immune cells which can recognise and kill the cancer.

But it is a fine line to make sure that the immune system doesn’t damage the brain in doing so.

“We want the receptors to bind with the tumour and have the immune cells, or T cells, kill the tumour cells, but not be so activated that they cause inflammation in a really delicate location like the brain,” she says.

“It’s a bit like using volume control to tune the receptors to make them safer.” 

Jenkins says the process has been shown to cure brain cancer in mice and is now ready for clinical trials on humans if they can get enough funding.

 Jenkins did her PhD in immunology at the University of Melbourne with Peter Doherty, who was awarded a Nobel Prize for his work on T cells. She went on to do postdoctoral work at Oxford and Cambridge universities – the first Indigenous Australian to attend the universities as a postdoctoral research fellow.

 Returning to Australia, she worked at the Peter MacCallum Cancer Centre in Melbourne.

She worked on broader research into cancer until her friend’s comments prompted her to focus on brain cancer.

Her pioneering work on brain cancer at the Walter and Eliza Hall Institute was originally funded by philanthropists, some of whom were parents of young children who had died from brain cancer.

“It’s heartbreaking,” she says, of her conversations with some of these parents.

Her closeness with the medical fraternity allowed her to have first hand access to cancer patients and to the brain tissues of those who had died.

She and her team regularly deal with people who they know will not survive their cancer. “It can be quite confronting for the team,” she says.

Jenkins says there is no known cause of brain cancer. While still rare, it is on the increase. 

She says there needs to be a sense of urgency to find treatments for brain cancer.

‘Thirty years ago, 90 per cent of kids who were diagnosed with it died – now 90 per cent survive’

Jenkins believes that a cure can be found for brain cancer if researchers can get enough funding.

“Breast cancer is a perfect example. Thirty years ago, 75 per cent of women with a diagnosis died within five years of that diagnosis. Now, more than 90 per cent survive for more than five years. That’s due to massive investments into medical research as well as education around awareness of early detection.” 

“It’s the same with leukaemia. Thirty years ago, 90 per cent of kids who were diagnosed with it died – now 90 per cent survive.

“Imagine if we had the same resources to combat brain cancer.” 

“We need to dream big and think about if we had the same collective action – if the whole world decided it was going to cure brain cancer.”

Thanks to the support of philanthropists, Jenkins and her team have been able to get their work to the level where they could attract government funding from the National Health and Medical Research Council (NHMRC).

 But the constant need to apply for grants makes the future uncertain for her staff.

While there is research on brain cancer happening around the world, her team is doing pioneering work in assessing the different types of cancer tumours and working out how to treat them.

She says cancer treatment of the future, including for brain cancer, will focus on the specific nature of the cancer in different people, tailoring treatment to individual needs in more personalised medicine.

Brain tumours can vary, leading to different responses to treatment. “We are developing a powerful new therapy and treatment, but it requires investment to take it to the next level and to see Australia have its first clinical trials using personalised cell therapy to treat brain cancer.”

You can her presentation from the Sohn Hearts & Minds conference here.


This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Recent Posts

Read the latest insights
A curated list of HM1 investor updates, portfolio news and other interesting articles.
Read More
Nine top stock picks to prepare your portfolio for 2025
Health care, ride-sharing, and the emerging world of YouTube entertainers are among the industries leading investors have picked for growth in 2025.
Resources fundies reveal top picks ahead of ‘stellar’ 2025
Some of Australia’s biggest resources funds are gearing up for a bumper start to the new year.
Qiao Ma: finding killer companies, surviving the GFC & why founders win
Qiao Ma, Portfolio Manager of the Munro Partners joins Owen Rask on The Australian Investors Podcast.
10 top fund managers reveal their long-term stock picks
With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors. 
 

Nine top stock picks to prepare your portfolio for 2025

Health care, ride-sharing, and the emerging world of YouTube entertainers are among the industries leading investors have picked for growth in 2025.

Read More
January 21st, 2025
 

Resources fundies reveal top picks ahead of ‘stellar’ 2025

Some of Australia’s biggest resources funds are gearing up for a bumper start to the new year.

Read More
January 6th, 2025
 

Qiao Ma: finding killer companies, surviving the GFC & why founders win

Qiao Ma, Portfolio Manager of the Munro Partners joins Owen Rask on The Australian Investors Podcast.

Read More
January 6th, 2025
 

10 top fund managers reveal their long-term stock picks

With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors. 

Read More
December 28th, 2024
 

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
December 19th, 2024
 

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
December 10th, 2024
 

Nick Griffin – The Nvidia story is not over

Nick Griffin, Founding Partner & Chief Investment Officer of Munro Partners joined the Equity Mates podcast in their Summer Series.

Read More
December 9th, 2024
 

HM1 CEO Succession

Hearts and Minds Investments Limited advises that Paul Rayson intends to retire from the position of Chief Executive Officer, effective 19 February 2025.

Read More
December 5th, 2024
 

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
November 20th, 2024
 

These rock-star stock picks could get markets talking next year

Eleven rock stars of international and local funds management took to stage – each tasked with picking and pitching one company whose shares will take off over the next year.

Read More
November 18th, 2024
 

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
November 17th, 2024
 

Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

Read More
November 15th, 2024
 

Sohn ASX stock pick: Ellerston Capital’s Chris Kourtis backs Perpetual

Chris Kourtis has put his biggest bet on embattled Perpetual – picking one of the most hated stocks on the ASX – that he believes will soon be the ‘cheapest listed asset manager of scale in the universe’.

Read More
November 15th, 2024
 

AI start-ups a threat to incumbent big companies

Paul Bassat predicts emerging artificial intelligence companies will disrupt sectors and overtake established incumbent companies just as rapidly as the seismic shifts that took place when the internet emerged in the mid-1990s.

Read More
November 15th, 2024
 

Howard Marks and Sohn’s big stars reveal seven rules for investing

Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.

Read More
November 15th, 2024
 

Sohn investors position for bullish but bumpy Trump ride

Australia and the rest of the world must adjust to a new Trump presidency that will deliver an expected bull market but also disruption, with the leader in waiting prepared to “create pain” to get his way.

Read More
November 15th, 2024
 

Sohn stock picker experts name best shares to invest in for year ahead

‍Don’t overlook down and out silver miners, legacy skincare brands ready for a revival and a big financial company suffering from a severe case of shareholder wealth destruction.

Read More
November 15th, 2024
 

Eleven stock tips from Sohn to get you through 2025

“There’s no finer place for the finance festival than in the festival city,” said Matthew Grounds. He, along with fellow Barrenjoey co-executive chairman Guy Fowler and investor Gary Weiss, is one of Sohn’s driving forces.

Read More
November 15th, 2024
 

Sohn Hearts & Minds Investments fund targets $1.5bn valuation

‍Hearts & Minds Investments chair Chris Cuffe is hoping for HM1 to grow to more than $1.5bn in the next five years.

Read More
November 14th, 2024
 

Galaxy Digital CEO Mike Novogratz believes bitcoin will hit $US100k

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for cryptocurrency, says US billionaire Mike Novogratz.

Read More
November 9th, 2024
 

Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.

Read More
November 6th, 2024
 

Antipodes’ Ross says short-term wealth hinges on US election

The portfolio manager says defensive stocks pose a bigger risk than the magnificent seven for investors that are overexposed to the American sharemarket.

Read More
November 5th, 2024
 

Concentration risk key for investors: Antipodes Partners’ Vihari Ross

The concentration risk in global stock indexes that has built up during the strong rise over the past year must now be a key consideration for global investors, according to Vihari Ross.

Read More
November 5th, 2024
 

The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Read More
November 5th, 2024
 

Why this fundie wants you to ‘wince’ at his stock picks

When fund managers come to pitch their favourite stock at the annual Sohn Hearts & Minds conference, there are two ways they can go: they can play it safe, or they can take a risk and shock the room.

 

Read More
October 29th, 2024
 

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Read More
October 27th, 2024
 

Meet the 2024 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share eleven new managers for 2024. 

Read More
October 22nd, 2024
 

Chris Kourtis is on a winning streak. Here’s his next ASX pick

Chris Kourtis of Ellerston Capital thinks he’s found another winner and thinks it’s the last chance to have a bite at the cherry before the strategy plays out.

Read More
October 21st, 2024
 

Why Ellerston Capital’s Chris Kourtis plans to back a ‘hated’ stock

Chris Kourtis of Ellerston Capital plans to tip one of the “most hated” stocks in Australia when he presents at the 2024 Sohn Hearts & Minds Conference.

Read More
October 21st, 2024
 

Alex Pollak champions rewards of disruptive investment

Alex Pollak’s funds management company Loftus Peak rode the Nvidia wave and he is now looking at more opportunities in disruptive industry stocks.

Read More
October 14th, 2024